APA (7th ed.) Citation

I, K., C, P., Y, C., K, B., M, D., S, H., . . . T, S. (2025). SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target. Cell death & disease, 16(1), 754. https://doi.org/10.1038/s41419-025-08084-z

Chicago Style (17th ed.) Citation

I, Krossa, et al. "SETDB1 Is Critically Required for Uveal Melanoma Growth and Represents a Promising Therapeutic Target." Cell Death & Disease 16, no. 1 (2025): 754. https://doi.org/10.1038/s41419-025-08084-z.

MLA (9th ed.) Citation

I, Krossa, et al. "SETDB1 Is Critically Required for Uveal Melanoma Growth and Represents a Promising Therapeutic Target." Cell Death & Disease, vol. 16, no. 1, 2025, p. 754, https://doi.org/10.1038/s41419-025-08084-z.